AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairmentKELLS, A. P; HENRY, R. A; CONNOR, B et al.Gene therapy (Basingstoke). 2008, Vol 15, Num 13, pp 966-977, issn 0969-7128, 12 p.Article

Magnetic Resonance Imaging-Guided Delivery of Adeno-Associated Virus Type 2 to the Primate Brain for the Treatment of Lysosomal Storage DisordersSALEGIO, E. Aguilar; KELLS, A. P; FIANDACA, M. S et al.Human gene therapy. 2010, Vol 21, Num 9, pp 1093-1103, issn 1043-0342, 11 p.Article

Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's diseaseTATTERSFIELD, A. S; CROON, R. J; LIU, Y. W et al.Neuroscience. 2004, Vol 127, Num 2, pp 319-332, issn 0306-4522, 14 p.Article